203 related articles for article (PubMed ID: 21321994)
1. Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD.
Olguín HC; Patzlaff NE; Olwin BB
J Cell Biochem; 2011 May; 112(5):1410-7. PubMed ID: 21321994
[TBL] [Abstract][Full Text] [Related]
2. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.
Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS
Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712
[TBL] [Abstract][Full Text] [Related]
3. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
[TBL] [Abstract][Full Text] [Related]
4. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
Barr FG
Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
[TBL] [Abstract][Full Text] [Related]
5. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis.
Graf Finckenstein F; Shahbazian V; Davicioni E; Ren YX; Anderson MJ
Oncogene; 2008 Mar; 27(14):2004-14. PubMed ID: 17922034
[TBL] [Abstract][Full Text] [Related]
6. A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR.
Galindo RL; Allport JA; Olson EN
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13439-44. PubMed ID: 16938866
[TBL] [Abstract][Full Text] [Related]
7. A chimeric RNA characteristic of rhabdomyosarcoma in normal myogenesis process.
Yuan H; Qin F; Movassagh M; Park H; Golden W; Xie Z; Zhang P; Sklar J; Li H
Cancer Discov; 2013 Dec; 3(12):1394-403. PubMed ID: 24089019
[TBL] [Abstract][Full Text] [Related]
8. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
Barr FG; Qualman SJ; Macris MH; Melnyk N; Lawlor ER; Strzelecki DM; Triche TJ; Bridge JA; Sorensen PH
Cancer Res; 2002 Aug; 62(16):4704-10. PubMed ID: 12183429
[TBL] [Abstract][Full Text] [Related]
10. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
11. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
Collins MH; Zhao H; Womer RB; Barr FG
Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
[TBL] [Abstract][Full Text] [Related]
12. AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.
Jothi M; Nishijo K; Keller C; Mal AK
Cell Cycle; 2012 Mar; 11(5):895-908. PubMed ID: 22333587
[TBL] [Abstract][Full Text] [Related]
13. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.
Bennicelli JL; Advani S; Schäfer BW; Barr FG
Oncogene; 1999 Jul; 18(30):4348-56. PubMed ID: 10439042
[TBL] [Abstract][Full Text] [Related]
14. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.
Davis RJ; Barr FG
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312
[TBL] [Abstract][Full Text] [Related]
15. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.
Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R
Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
Hu Q; Yuan Y; Wang C
PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156
[TBL] [Abstract][Full Text] [Related]
17. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
18. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression.
Tomescu O; Xia SJ; Strezlecki D; Bennicelli JL; Ginsberg J; Pawel B; Barr FG
Lab Invest; 2004 Aug; 84(8):1060-70. PubMed ID: 15184910
[TBL] [Abstract][Full Text] [Related]
19. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG
J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192
[TBL] [Abstract][Full Text] [Related]
20. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
Davicioni E; Finckenstein FG; Shahbazian V; Buckley JD; Triche TJ; Anderson MJ
Cancer Res; 2006 Jul; 66(14):6936-46. PubMed ID: 16849537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
